Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Inventory Average (2016 - 2019)

Aptevo Therapeutics' Inventory Average history spans 4 years, with the latest figure at $6.8 million for Q4 2019.

  • For Q4 2019, Inventory Average rose 136.72% year-over-year to $6.8 million; the TTM value through Dec 2019 reached $6.8 million, up 136.72%, while the annual FY2019 figure was $4.0 million, 66.65% up from the prior year.
  • Inventory Average for Q4 2019 was $6.8 million at Aptevo Therapeutics, down from $7.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $15.9 million in Q3 2016 and bottomed at $1.1 million in Q4 2017.
  • The 4-year median for Inventory Average is $4.4 million (2017), against an average of $5.2 million.
  • The largest annual shift saw Inventory Average crashed 81.18% in 2017 before it soared 165.88% in 2019.
  • A 4-year view of Inventory Average shows it stood at $6.0 million in 2016, then plummeted by 81.18% to $1.1 million in 2017, then skyrocketed by 154.04% to $2.9 million in 2018, then surged by 136.72% to $6.8 million in 2019.
  • Per Business Quant, the three most recent readings for APVO's Inventory Average are $6.8 million (Q4 2019), $7.2 million (Q3 2019), and $5.7 million (Q2 2019).